{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T11:29:12Z","timestamp":1745494152492},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.medcli.2017.01.021","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T05:01:22Z","timestamp":1488258082000},"page":"495-497","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Deprivaci\u00f3n androg\u00e9nica en c\u00e1ncer de pr\u00f3stata y riesgo de aparici\u00f3n de litiasis renal. Resultados de un estudio de casos y controles"],"prefix":"10.1016","volume":"148","author":[{"given":"Enrique Javier","family":"D\u00edaz Conval\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Carmen","family":"Cano-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Mij\u00e1n-Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Arrabal-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"Arrabal-Polo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"C\u00f3zar-Olmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2017.01.021_bib0055","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.eururo.2013.11.002","article-title":"EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur Urol."},{"key":"10.1016\/j.medcli.2017.01.021_bib0060","doi-asserted-by":"crossref","first-page":"T119","DOI":"10.1530\/ERC-13-0467","article-title":"Androgen deprivation therapy complications","volume":"21","author":"Allan","year":"2014","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.medcli.2017.01.021_bib0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4111\/kju.2015.56.1.12","article-title":"Metabolic effects of androgen deprivation therapy","volume":"56","author":"Choi","year":"2015","journal-title":"Korean J Urol."},{"key":"10.1016\/j.medcli.2017.01.021_bib0070","doi-asserted-by":"crossref","first-page":"R371","DOI":"10.1530\/ERC-14-0172","article-title":"Muscle and bone effects of androgen deprivation therapy: Current and emerging therapies","volume":"21","author":"Cheung","year":"2014","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.medcli.2017.01.021_bib0075","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur Urol."},{"key":"10.1016\/j.medcli.2017.01.021_bib0080","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1464-410X.2012.11774.x","article-title":"Androgen deprivation therapy: Evidence-based management of side effects","volume":"111","author":"Ahmadi","year":"2013","journal-title":"BJU Int."},{"issue":"Suppl 5","key":"10.1016\/j.medcli.2017.01.021_bib0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bju.12964","article-title":"Adverse effects of androgen-deprivation therapy in prostate cancer and their management","volume":"115","author":"Rhee","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.medcli.2017.01.021_bib0090","first-page":"285","article-title":"Metabolic syndrome and nephrolithiasis","volume":"3","author":"Ramaswamy","year":"2014","journal-title":"Transl Androl Urol."},{"key":"10.1016\/j.medcli.2017.01.021_bib0095","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ki.2010.473","article-title":"Nephrolithiasis-associated bone disease: Pathogenesis and treatment options","volume":"79","author":"Sakhaee","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.medcli.2017.01.021_bib0100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.acuro.2011.01.008","article-title":"Loss of bone mass in patients with prostate cancer subjected to androgenic deprivation","volume":"35","author":"Morote","year":"2011","journal-title":"Actas Urol Esp."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317300921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317300921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:50:57Z","timestamp":1536022257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775317300921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0025775317300921"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2017.01.021","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deprivaci\u00f3n androg\u00e9nica en c\u00e1ncer de pr\u00f3stata y riesgo de aparici\u00f3n de litiasis renal. Resultados de un estudio de casos y controles","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2017.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}